Thermo Fisher claims its tests can detect Omicron variant accurately

By Akshay Kedari  | Date: 2021-11-30

Thermo Fisher claims its tests can detect Omicron variant accurately

The emergence of the Omicron variant of coronavirus, which has forced some countries to once again seal off their borders, is being seen as a catalyst to prolonging the pandemic. The accurate detection of the variant is a major concern, however, Thermo Fisher Scientific Inc. recently announced that its COVID-19 diagnostic tests can precisely do so.

Last week, World Health Organization (WHO) categorized Omicron variant as a SARS-CoV-2 'variant of concern', alerting that it could spread even faster than the other strains.

Thermo Fisher stated that its TaqPath COVID-19 tests can provide accurate findings even if one of the gene targets is mutated.

Chief operating officer of Thermo Fisher, Mark Stevenson, asserted that the tests can be utilized to not only detect COVID-19 but also the Omicron variant.

Mr. Stevenson added that TaqPath is the only COVID-19 diagnostic test that is both FDA-approved and can determine whether the infection is caused by the new variant and not by any other variant with similar traits, such as the Alpha variant, for which the test samples must still be sent to the lab for sequencing.

He also revealed that Thermo Fisher is preparing to expand the production of its test kits to fulfill the demand from countries in Africa and more as they continue to track the spread of the new variant.

It is to be noted that other COVID-19 tests, such as from Abbott Laboratories and Roche Holding AG, can also be used to diagnose positive instances of the COVID-19 disease caused by Omicron variant. Although, only Thermo Fisher has proven that its test can identify the new variant.

Omicron, which was first discovered in Southern Africa, has now spread to Australia, Belgium, Botswana, United Kingdom, Denmark, Germany, Hong Kong, Israel, Italy, Netherlands, France, South Africa, Canada, and United States.

Meanwhile, WHO is teaming up with experts to determine the possible impact of Omicron variant on the existing COVID-19 countermeasures, such as vaccinations.

Source: https://news.yahoo.com/thermo-fisher-says-covid-19-061039915.html

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More >>

More News By Akshay Kedari

Fitbit faces privacy complaints in EU over alleged unlawful data exports

Fitbit faces privacy complaints in EU over alleged unlawful data exports

By Akshay Kedari

Fitbit, a Google company, is reportedly facing a series of privacy complaints within the European Union. These complaints revolve around allegations that the company is engaging in unlawful exporting of user data, thereby violating the EU's strin...

Social network X makes API changes impacting developers & enterprise clients

Social network X makes API changes impacting developers & enterprise clients

By Akshay Kedari

Social network X, previously known as Twitter, has reportedly unveiled more modifications that involve the retirement of certain legacy API endpoints. The company implemented adjustments to its API pricing in March, resulting in elevated costs for...

Zapata AI and IonQ joins hands to push boundaries of Generative AI

Zapata AI and IonQ joins hands to push boundaries of Generative AI

By Akshay Kedari

Zapata AI, a software enterprise dedicated to addressing intricate computational challenges, has reportedly unveiled a strategic partnership with IonQ, a leading figure in quantum computing hardware and commercial quantum application advancement. The...

Meta unveils AudioCraft for audio & music creation using Generative AI

Meta unveils AudioCraft for audio & music creation using Generative AI

By Akshay Kedari

The tech giant Meta has reportedly introduced AudioCraft, a framework capable of generating high-quality audio and music based on short text prompts. The AudioCraft framework aims to simplify the use of generative models for audio by providing a c...

GSK Pharma reports 11% surge in Q1 profit fueled by Vaccine Demand

GSK Pharma reports 11% surge in Q1 profit fueled by Vaccine Demand

By Akshay Kedari

GlaxoSmithKline Pharmaceuticals, the Indian arm of GSK plc based in the UK, reportedly recorded an 11% increase in its first-quarter profit, driven by robust demand for its vaccines. According to the company's statement, the consolidated profi...